EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Adjuvant Trastuzumab Emtansine or Trastuzumab in Initially HER2-Positive Breast Cancer with Residual IHC 0–2+: A Retrospective Multicenter Cohort

Serdar İleri, Mehmet Sıddık Dilek, Cahit Uçar, Eyyüp Çavdar, Fatma Keskin Uzundere, Ayberk Bayramgil, Oğuzhan Selvi, Sercan Olcar, Hilal Karakaş, İsmail Bayrakçı, Ali Kaan Güren, Nazım Can Demircan und 14 weitere

Breast Cancer: Targets and Therapy · 2026-11 · Volume 18 · 1-17

DOI: 10.2147/bctt.s659921 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-11. Verfasst von Serdar İleri und 25 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

İleri, S., Dilek, M. S., Uçar, C., Çavdar, E., Uzundere, F. K., Bayramgil, A., Selvi, O., Olcar, S., Karakaş, H., Bayrakçı, İ., Güren, A. K., Demircan, N. C., Baykara, M., Arıstak, E. B., Kölemen, E., Çabuk, D., Tüzün, E. K., Ertürk, İ., Güven, D. C., …, & Urakçı, Z. (2026). Adjuvant Trastuzumab Emtansine or Trastuzumab in Initially HER2-Positive Breast Cancer with Residual IHC 0–2+: A Retrospective Multicenter Cohort. Breast Cancer: Targets and Therapy, Volume 18, 1-17. https://doi.org/10.2147/bctt.s659921

Vancouver

İleri S, Dilek MS, Uçar C, Çavdar E, Uzundere FK, Bayramgil A, et al. Adjuvant Trastuzumab Emtansine or Trastuzumab in Initially HER2-Positive Breast Cancer with Residual IHC 0–2+: A Retrospective Multicenter Cohort. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-17. doi:10.2147/bctt.s659921

BibTeX
@article{leri2026,
  author = {İleri, Serdar and Dilek, Mehmet Sıddık and Uçar, Cahit and Çavdar, Eyyüp and Uzundere, Fatma Keskin and Bayramgil, Ayberk and Selvi, Oğuzhan and Olcar, Sercan and Karakaş, Hilal and Bayrakçı, İsmail and Güren, Ali Kaan and Demircan, Nazım Can and Baykara, Meltem and Arıstak, Esma Bayrak and Kölemen, Erdem and Çabuk, Devrim and Tüzün, Esmanur Kaplan and Ertürk, İsmail and Güven, Deniz Can and Bardakci, Murat and Özkan, Vahap and Arcagök, Murat and Tunç, Sezai and Karhan, Oğur and Ozan, Mahsum and Urakçı, Zuhat},
  title = {Adjuvant Trastuzumab Emtansine or Trastuzumab in Initially HER2-Positive Breast Cancer with Residual IHC 0–2+: A Retrospective Multicenter Cohort},
  journal = {Breast Cancer: Targets and Therapy},
  year = {2026},
  volume = {Volume 18},
  pages = {1--17},
  doi = {10.2147/bctt.s659921}
}
Kostenlos starten →